Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

Incidence of bone metastases and skeletal-related events in breast cancer patients: A population-based cohort study in Denmark

(2011) Annette Ø Jensen et al.   BMC CANCER

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

(2011) Karim Fizazi et al.   LANCET

Skeletal-related events in urological cancer patients with bone metastasis: A multicenter study in Japan

(2010) Akira Yokomizo et al.   INTERNATIONAL JOURNAL OF UROLOGY

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

(2010) Alison T. Stopeck et al.   JOURNAL OF CLINICAL ONCOLOGY

Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)

(2010) Mette Nørgaard et al.   JOURNAL OF UROLOGY

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

(2010) Jong-Mu Sun et al.   LUNG CANCER

Validity of the recorded International Classification of Diseases, 10th edition diagnoses codes of bone metastases and skeletal-related events in breast and prostate cancer patients in the Danish National Registry of Patients

(2010) Annette Østergaard Jensen   Clinical Epidemiology

Zoledronic acid and skeletal complications in patients with solid tumors and bone metastases

(2008) Hind T. Hatoum et al.   CANCER